1 2 Trisomy for human chromosome 21 (Hsa21) results in Down syndrome (DS), one of the 3 most genetically complex conditions compatible with human survival. Assessment of the 4 physiological consequences of dosage-driven overexpression of individual Hsa21 genes 5 during early embryogenesis and the resulting contributions to DS pathology in mammals 6
ABSTRACT: 1 2
Trisomy for human chromosome 21 (Hsa21) results in Down syndrome (DS), one of the 3 most genetically complex conditions compatible with human survival. Assessment of the 4 physiological consequences of dosage-driven overexpression of individual Hsa21 genes 5 during early embryogenesis and the resulting contributions to DS pathology in mammals 6 are not tractable in a systematic way. A recent study looked loss-of-function of C. 7 elegans orthologues of Hsa21 genes and identified ten candidates with behavioral 8 phenotypes, but the equivalent over-expression experiment has not been done. We 9 turned to zebrafish as a developmental model and, using a number of surrogate 10 phenotypes, we screened Hsa21 genes for dosage sensitive effects on early 11 embyrogenesis. We prepared a library of 164 cDNAs of conserved protein coding 12 genes, injected mRNA into early embryos and evaluated up to 5 days post-fertilization 13 (dpf). Twenty-four genes produced a gross morphological phenotype, 11 of which could 14 be reproduced reliably. Seven of these gave a phenotype consistent with down 15 regulation of the sonic hedgehog (Shh) pathway; two showed defects indicative of 16 defective neural crest migration; one resulted consistently in pericardial edema; and one 17 was embryonic lethal. Combinatorial injections of multiple Hsa21 genes revealed both 18 additive and compensatory effects, supporting the notion that complex genetic 19 relationships underlie end phenotypes of trisomy that produce DS. Together, our data 20 suggest that this system is useful in the genetic dissection of dosage-sensitive gene 21 effects on early development and can inform the contribution of both individual loci and 22
their combinatorial effects to phenotypes relevant to the etiopathology of DS. 23
INTRODUCTION 1
Down syndrome (DS) occurs in about one of 700 live births due to trisomy for human 2 chromosome 21 (Hsa21) [1] . The consequent ~1.5 fold over expression of most genes 3 on Hsa21 can result in more than 80 clinical phenotypes, many of which originate during 4 prenatal development and vary in both severity and penetrance [2] [3] [4] . Among the most 5 consistent features are cognitive impairment, characteristic craniofacial dysmorphism, 6 smaller and hypocellular brain and Alzheimer histopathology [5, 6] . Individuals with DS 7 also have a greatly increased risk of congenital heart disease, Hirschsprung disease 8 and acute megakaryoblastic leukemia in children. However, the incomplete penetrance 9 of many DS phenotypes indicates that trisomy 21 is not sufficient to cause most of these 10
conditions, suggesting an important role for allelic variation of Hsa21 genes and 11 additional modifier genes, as well as potential environmental and stochastic factors [7-12 9]. DS is one of the few autosomal aneuploidies that is compatible with life, likely related 13
to Hsa21 being the smallest autosome and having very low gene density. Estimates of 14 the gene content on Hsa21 range from ~300-600 genes/transcripts, of which 162 have 15 been identified as well-conserved in other mammals [10] . Understanding how trisomy 16 for these genes affects the presentation of the phenotypes in DS is a major focus for 17 research into this condition. 18
A major challenge in understanding mechanisms of gene action in DS is that 19 trisomy 21 is present from conception and every cell is affected, causing effects 20 throughout development. Trisomic genes may have a primary effect directly on cellular 21 function or may secondarily affect expression and regulation of disomic genes. Trisomy-22
induced changes in one cell type could alter interactions with neighboring cells, thus 23 1
Development of the clone set and initial screen: 2
In a detailed annotation of transcripts from Hsa21, Sturgeon and Gardiner identified 162 3 genes that are highly conserved with mouse [10] . We assembled a set of Hsa21 cDNA 4 clones consisting of 148 of these conserved genes and 15 human-specific genes [10, 5 21 ]. The 15 genes that are not conserved include DSCR genes, long intergenic non-6 coding RNA, and Hsa21 open reading frames. One gene, SYNJ1, is represented by two 7 splice isoforms, for a total of 164 cDNAs (Supplemental Table 1 ). The majority of clones 8 are from the InVitrogen UltimateORF collection library (now Thermo Fisher Scientific's 9
Ultimate ORF Clones), subcloned into the pCS2+ destination vector ( Figure 1 ) [22] . 10 Thus we selected highly conserved genes from this carefully annotated set for which 11 cDNA could be obtained and which could be cloned into the pCS2+ vector and 12 transcribed. Additional sources and vectors are described in Supplemental Table 1 . 13
14
Next we used Mouse Mine to interrogate the human gene list and compare it to 15 homology data sets, HomoloGene and Panther, to identify orthologs and ohnologs 16 between zebrafish and mouse (Supplemental Table 1 ) [23] , [24] ). In zebrafish, 125 of 17 the 163 Hsa21 genes (77%) are conserved; 35 of those (28%) are represented by more 18 than one zebrafish ortholog (ohnolog). The number of Hsa21 genes conserved with 19 zebrafish is similar to published reports for all human genes (71%), but the proportion of 20
Hsa21 genes with ohnologs is less than the 47% rate for all human genes [25] . 21
22
Zebrafish Screen 23
We synthesized mRNAs from the Hsa21 cDNA clones and injected each one into ~100 1 zebrafish embryos at the 1-2 cell stage at 10, 50 and/or 100 pg (Supplemental Table 2) , 2 ranges that have been used in similar studies previously [20] . More than 50,000 3 embryos were screened for the presence of gross morphological changes present at 4 frequencies greater than controls, typically at five days post fertilization (dpf), but also 5 earlier if mandated by the presence of clear pathologies. We focused primarily on three 6 broad phenotypic classes: a) U-shaped somites and cyclopia, two phenotypes 7 associated frequently but not exclusively with defects in the ciliome and Shh signaling 8 pathway; b) craniofacial abnormalities and pigment differences, which may be related to 9 aberrations affecting neural crest cells; and c) pericardial edema, which can have a 10 number of causes including a structural heart defect ( Figure 2 , Table 1 ). We recorded 11 the number of surviving embryos, the phenotype, and the percentage that were affected 12 (Table 2) . 13
14
Of the 164 RNAs, 24 showed a phenotype after the initial screen (Supplemental Tables  15   2 and 3) ; the remaining 140 did not yield a significant number of affected embryos. 16
Thus, again consistent with previous studies [20], our approach is not generally toxic to 17 zebrafish embryos. Expression of 14 of these 24 genes gave a phenotype consistent 18 with perturbation of the ciliome/Shh-pathway (eight with U-shaped somites and a 19 partially overlapping set of six with cyclopia). An additional seven genes resulted in 20 phenotypes that may be due to neural crest defects (four with craniofacial abnormalities 21 and three with pigment differences). Finally, one gene induced pericardial edema, one 22 resulted in dysmorphic fins, and one exhibited elevated lethality ( Table 1 
and 23
Supplemental Table 2 ). Of the 24 first-round candidates, 19 are conserved in both 1 mouse and zebrafish; four are conserved in between human and mouse but not 2 zebrafish (BACH1, Clic6, MAP3K7CL, SPATC1L); and one gene (LINC00313) is human 3 specific. Six of the 19 conserved Hsa21 genes have ohnologs in zebrafish 4 (Supplemental Table 1 ). 5
6
Fresh mRNA was prepared from these first-round candidates and injections were 7 repeated. Eleven candidates recapitulated the original phenotypes robustly, seven from 8 the Shh group, two with neural crest related phenotypes, and the single genes resulting 9 in pericardial edema and embryonic lethality, respectively ( Figure 2 , Table 2 , 10
Supplemental Tables 2 and 3 ). Of the 11 second-round candidates conserved in 11 zebrafish, two have ohnologs in zebrafish (JAM2 and CBR3). 12
13

Phenotypic rescue via Morpholinos 14
The first indication that the phenotypes observed in repeated injections are due to the 15 expression of the specific RNA and not to a general RNA effect is that there are at least 16 140 clones that produced no phenotype in this screen. Next, we selected randomly four 17 of the candidate genes and performed a rescue experiment using morpholino (MO)-18 based knockdown. We designed translation-blocking MOs against the human copies of 19 SOD1, RWDD2B or CCT8 to target the ATG start site of the gene to suppress 20 specifically the introduced human mRNA. We also designed MOs to knock down the 21 endogenous zebrafish orthologs of JAM2, using a previously validated MO [26] . One 22 hundred embryos were injected with 2ng MO and 100pg of RNA. For all four genes, 23 injection of the RNA alone produced significantly higher penetrance than the uninjected 1 controls, the MO alone, or the MO+RNA injected embryos (p<0.05 Figure 3 ). For SOD1, 2 RWDD2B, and CCT8 the MO+RNA was not significantly different from the controls. 3 JAM2 MO+RNA showed significantly lower penetrance of heart edema relative to RNA-4 injection alone [27] . The JAM2 experiment suggests that this phenotype is a product of 5 additive effects of the human cDNA with its fish orthologs/ohnologs.
7
Dosage and Gene expression patterns 8
This screen was designed to identify Hsa21 genes with an effect on broad aspects of 9 early embryonic development and not as a study of human dosage effects on fish (see 10
Discussion). For those cDNAs producing phenotypes, penetrance was generally 11 correlated with but not directly proportional to penetrance (Supplemental Table 2 ). In the 12 case of ERG, however, the frequency of embryonic lethality was proportional to RNA 13 dose. Approximately 1/3 of embryos (24/67) survived after injection with 10 pg ERG 14 RNA, while 14% survived injection with 50 pg and 6.5% (24/358) were alive two days 15 after injection of 100 pg. Retrospective examination also showed somewhat elevated 16 mortality following injection of either of the additional two ETS family transcription 17 factors in the Hsa21 clone set, ETS2 and GABPA (Supplemental Table 2 ). HMGN1 also 18 showed a trend toward higher lethality. 19
Among the final candidates with repeatable phenotypes, only ERG showed 20 increased lethality with increasing RNA concentrations. The 10 remaining candidates 21 were injected at three or more concentrations ranging from 10pg to 200pg but no 22 correlation between dosage and penetrance was observed (Supplemental Figure 1) . 23
[20, 28]. We also chose two genes, SOD1 and RRP1, to look for effects of low RNA 1 doses. These genes were injected at 2pg and 5pg, and the penetrance of U-shaped 2 somites was examined. Both genes showed low penetrance of the phenotype at these 3 low doses, although each reproducibly produced a phenotype after injection of 50-4 100pg (Supplemental Figure 2) . 5
Nine of the eleven candidates have zebrafish homologs, the exceptions being 6 C21ORF84 and CBR3. For eight of these genes, representative in situ hybridization 7 data are available in ZFIN [29] . In most cases, the structure(s) affected by RNA injection 8 is consistent with the in situ expression data. For example, sod1, rrp1 and ybey are 9 expressed in somites, cct8 is expressed ubiquitously, jam2 shows expression in the 10 region of the developing heart and erg is expressed in the vasculature (Table 2) . pofut2 11 is expressed in the brain and eye [30]; knockdown of a C. elegans homolog of this gene 12 produced a neuromuscular phenotype [15] . pcbp3 is expressed in the retina and 13 telencephalon beginning at the Prim 15 stage [29] . No information about rwdd2b 14 expression was available in ZFIN. Ten of the eleven candidates have mouse orthologs 15 whose expression has been examined at mid-gestation showing that the genes are 16 expressed in the corresponding tissues during embryonic development in mouse ( Table  17 2, [31, 32] ). C21ORF84 is a human specific lncRNA [21] . 18 19
Combinatorial injections 20
DS is a contiguous gene defect with effects on development that exceed those of 21 individual genes. Examination of all pairwise interactions of 163 genes would require 22 more than 13,000 pairs, posing a logistical challenge even in this system. We took an 23 initial step toward understanding this process with respect to a small set of candidate 1 genes. We first examined the subset of genes that produced possible Shh-related 2 phenotypes in our screen. SOD1, RWDD2B, YBEY, PCBP3, and RRP1 all produced U-3 shaped somites, POFUT2 resulted in cyclopia and C21ORF84-injected embryos 4 showed both phenotypes. We used C21ORF84 as the reference gene to pair with the 5 other six genes. For each set of pairwise injections, C21ORF84 was injected alone at 6 100pg, the second gene was injected alone at 100pg, and both genes were injected 7 together at 100pg each. 8
Injection of C21ORF84 plus YBEY, PCBP3 or POFUT2 showed a significant 9 increase in the frequency of embryos with U-shaped somites (Fig. 4, p<0 .05 for each 10 combination). For two genes, SOD1 and RWDD2B, there was not a significant 11 difference between the individual injections and the combinatorial injection. RRP1 alone 12 had a penetrance of 42%, the highest of all genes tested. This frequency was reduced 13 significantly in embryos injected with RRP1 and C21ORF84 together. 14 We repeated the pairwise injections using a different reference gene from this 15 group, SOD1. As in the previous experiment, SOD1 was injected individually and in 16 combination with one of the other six genes, and the embryos were examined for the 17 presence of U-shaped somites. In contrast to ORF84, SOD1 did not show an interaction 18 with any of the other six genes (Supplemental Figure 3 ). Finally, combinatorial injections 19 using C21ORF84 were repeated with freshly prepared RNAs at a separate institution 20 (by NAZ and CCL) as a means of independent replication. We observed a similar 21 increase in affected embryos upon injection of C21ORF84 with YBEY and PCBP3 22 compared to each gene alone. 23
We also selected candidate gene sets for combinatorial injection based on 1 reported roles in other systems and assessed them for possible combinatorial effects on 2 developmental phenotypes. Several genes associated previously with heart anomalies 3 in Down syndrome, SH3BGR, DCSR6 and ADAMTS1, were co-injected (30pg each). 4
This resulted in cyclopia in 3.6% and pericardial edema in a non-overlapping 3.6% of 5 embryos, whereas no controls were observed to have either edema or cyclopia, a trend 6 though not formally significant (Fisher's exact test, p=0.056 for either cyclopia or 7 edema). Several Hsa21 gene combinations have been implicated in the high frequency 8
of congenital heart disease in DS [33]. However, neither injection of all three collagens 9 together (COL6A1, COL6A2, COL18A1) nor coinjection of DSCAM and SH3BGR 10 produced a significant frequency of heart or other gross anatomical defects. was also found to have a neurobehavioral phenotype in a reciprocal loss-of-function 18 screen in C. elegans, indicating that it may be a good candidate for further study [15] . 19
There are several caveats to interpretation of this large scale screen. A negative 20 result in the screen does not rule out a contribution of that gene to DS. First, some 21 human genes could fail to produce an effect due to inefficient translation related to the 22 fact that these are mammalian mRNAs that may not be properly processed in fish. 23
Some human proteins may simply be hypo-or non-functional in zebrafish. Except for 1 SYNJ1, we selected a single isoform for the cDNA clone set. Next, DS is a contiguous 2 gene syndrome, with many interactions among the over-expressed genes and with 3 disomic genes at different stages of development [11, 36] . Finally, it should be clear that 4 this is not a study of the effects of dosage imbalance that occur in DS per se. Indeed, it 5 would be difficult to define what dose of a human mRNA might result in human protein 6 levels that, together with the orthologous fish proteins, replicate the functional 7 stoichiometry of DS in a fish embryo. Genes with ohnologs that function in a 8 complementary manner in fish represent an even more complicated situation when 9 additional expression of (possibly) related but non-identical function is introduced via the 10 human gene product. We did not observe a lower frequency of phenotypes among 11 genes with ohnologs than in the Hsa21 gene set as a whole, but the numbers are very 12 small. What we present is instead a screen for genes whose effects in this assay 13 indicate candidates to pursue in far more labor intensive studies of early mammalian 14 development. We have succeeded in one such application with Jam2 [27]. 15
The consistent occurrence of heart edema in zebrafish after injection of JAM2 16
RNA led us to examine this candidate in conjunction with increased penetrance of heart 17 defects in trisomic mouse models. Ts65Dn "Down syndrome" mice are trisomic for 18 about 104 genes orthologous to Hsa21 [37] . Breeding a null allele of the disomic gene, 19
Creld1, onto Ts65Dn significantly increased penetrance of septal defects in the heart 20 from 4% to 33% [38] . However, putting the same null allele on a related trisomy 21 (Ts1Cje) that was trisomic for about 81 of the genes triplicated in Ts65Dn, had no 22 impact on penetrance. Jam2 was one of the 23 genes that are trisomic in Ts65Dn but 23 not Ts1Cje, and one of 14 of these 23 that are expressed prenatally and/or in heart. 1
Based on its effect on heart development in the zebrafish screen, we tested its role in 2 mice by introducing a null allele of Jam2 to produce Ts65Dn;Creld1+/-;Jam2+/-mice 3 (returning Jam2 to the normal two copies). Instead of the expected increase in 4 penetrance in Ts65Dn;Creld1+/-, trisomy for all of the Ts65Dn genes except Jam2 5 resulted in penetrance in these mice that was the same as Ts65Dn alone (i.e., 4%) [27] . 6
Thus Jam2 is a trisomic potentiator of the disomic modifier of heart disease penetrance, 7
Creld1. This was the first demonstration of this type of genetic relationship in Down 8 syndrome. It would not have been possible to pursue this relationship for all 14 9
candidate genes trisomic in Ts65Dn but not in Ts1Cje in mice. 10
In this screen, it was somewhat surprising that several Hsa21 genes that have 11 been associated with robust phenotypes in mouse models of DS did not produce a support the use of D. rerio for this type of large-scale systematic screen. This system 23 represents a useful screening tool to identify individual candidate genes that may be 1 significant drivers of DS phenotypes. 2
We observed that some Hsa21 genes that produce phenotypes on their own can 3 interact in an additive manner, some have no apparent interaction and one pair had a 4 compensatory interaction. Compensatory interaction implies that in some cases 5 overexpression of one gene can balance the increased expression of another. To date, 6 several genes of major affect have been associated with manifestations of Down 7 syndrome in the mouse models. However, no single gene has been identified that is 8 sufficient to produce completely a complex developmental phenotype of DS, consistent 9
with the understanding of DS as a product of complex multi-gene interactions. Given the 10 large number of possible gene-gene interactions on chr21 alone, the system described 11
here provides a useful way to interrogate more complex interactions of non-contiguous 12 genes from the earliest stages of development. 
METHODS: 16
Hsa21 Gene Expression Library preparation 17 cDNAs were selected from lists of conserved genes on Hsa21 [2, 21]. For 84 genes, 18 plasmids containing the gene in the pENTR221 entry vector were obtained through the 19 Invitrogen UltimateORF collection. Of the remaining genes, 49 were subcloned from a 20 variety of vectors into one of the Invitrogen Gateway entry vectors (for complete list of 21 original vectors and sources see Supplemental Table 1 ) and 40 genes were 22
commercially cloned into the pCS2DEST vector. Entry vector clones were selected 23 using kanamycin and then sequenced to confirm correct insertion of the gene. All genes 1 in the entry vector were subcloned into the pCS2DEST vector (Addgene) using LR 2 clonase as previously described by Katzen et al. 2007 [47] . Genes in the pCSDEST 3 vector were selected by ampicillin. The entire pCS2+ vector clone set, named the 4
Hsa21
Gene Expression Set, is available through Addgene 5
(https://www.addgene.org/Roger_Reeves/). A limited set of HH pathway-related genes 6 was used as a training set for the system including recognition of the U-shaped somite 7 phenotype. 8 9
Bioinformatics 10
Comparisons of human, mouse, and zebrafish orthologs and ohnologs was performed 11
using MouseMine (www.mousemine.org, accessed October 1, 2017 [23] . Briefly, Hsa21 12 gene symbols for the 163 genes in this screen were uploaded as a list in MouseMine 13 and interrogated against the mouse and zebrafish using the HomoloGene data set from 14 NCBI and the PANTHER data set from MGI [24] . These lists were used to compile the 15 ortholog and ohnolog lists in Supplemental Table 1 . 16
17
In Vitro Transcription of mRNA 18
Plasmids were transcribed in vitro using the mMessage mMachine SP6 kit (Ambion, 19
Austin, TX). Plasmids were linearized and purified by precipitation. Transcribed 20 sequence reactions were treated with DNAse1 and mRNA was purified with lithium 21 chloride. mRNA quality and quantity were confirmed with a formaldehyde agarose gel 22 and the Nanodrop8000, respectively. 23 1
Zebrafish maintenance and injections 2
All procedures were approved by the Johns Hopkins University Animal Care and Use 3
Committee, protocol no. FI15M197. Zebrafish were raised in the FINZ center at the 4 Institute for Genetic Medicine (Johns Hopkins University) as described previously [48] . 5
Zebrafish were maintained at 28°C. Male and female Tubingen zebrafish were placed in 6 the same breeding tank in the morning and embryos were collected 30 minutes later. 7
One hundred embryos were then injected at the 1-4 cell blastula stage using a Zeiss 8
Stemi 2000 microscope and PV820 Pneumatic picopump injector. All genes were 9 injected at 50pg or 100pg and most were injected a second time at a different dose 10 (Supplemental. Table 2 ). All of those producing a phenotype were re-injected at 100pg. 11
Embryos were raised to 5 days post fertilization and then phenotyped using a Nikon 12 SMZ1500 microscope and imaged with NIS Elements Imaging Software. After imaging, 13 embryos were fixed in 4% PFA overnight then transferred to 100% Methanol for storage 14 at -20°C. For low dosage experiments, SOD1 and RRP1 were injected at 2pg, 5pg and 15 10pg and examined at 5 dpf. 16 17
Morpholino Rescue 18
Translation-blocking antisense morpholinos (MO) were designed against the human 19 sequence for the genes SOD1, RWDD2B, and CCT8, designed to bind to the ATG start 20 codon of the mRNA using Gene Tools (Philomath, OR): Hs-SOD1 5'-21
GCACGCACACGGCCTTCGTCGCCAT-3';
Hs-RWDD2B 5'-22
GCTGCATGGACAGCTCAATTTTCAT-3'; and
Hs-CCT8 5'-23
GAGCCTTGGGAACGTGAAGCGCCAT-3'. The MOs were checked using BLAST for 1 sequence specificity to the human homolog and insure that they were unique in the 2 either the human or zebrafish genomes. For each gene, 100 embryos were injected with 3 2ng MO, 100 embryos were injected with 100pg of mRNA and 100 embryos were 4 injected with both 2ng MO and 100pg mRNA; 100 uninjected embryos were used as a 5 control. Embryos were examined at 5 dpf for Hs-SOD1 and Hs-RWDD2B, 4 dpf for Hs-6 CCT8, and 24 hrs. post-fertilization (hpf) for Dr-JAM2. 7 8 Combinatorial Injections: 9
RNA from C21ORF84 was coinjected with RNA from the following genes: SOD1, 10 RWDD2B, RRP1, PCBP3, POFUT2, and YBEY. Each gene was injected individually at 11 100pg into 100 embryos, and then coinjected at 100pg of each RNA (200pg RNA). 12
Embryos were phenotyped at 24 hpf for the presence of U shaped somites and 13 cyclopia. Each coinjection was performed twice. The entire experiment was carried out 14 independently at a different institution (NAZ and CCL) injecting 200 pg mRNA into 50-15 100 embryos of the Tubingen line using the pairs listed and phenotyping at 24 hpf. 16
17
The combinatorial strategy was repeated using SOD1 as the reference gene and 18 coinjected with the same genes listed above. In this case, 50pg of each RNA was 19 injected individually into 100 embryos each, and then 50pg each of both RNAs were 20 coinjected into 100 embryos, with 100 control embryos. Embryos were examined at 21 24hpf for the presence of U-shaped somites. 22
Statistical Tests 1
For all injections, penetrance differences were examined using a Fisher's Exact test 2 with p<0.05 required for significance. coinjected with 6 other genes to look for synthetic effects. C21ORF84 was injected 20 individually at 100pg RNA, the other gene was injected individually at 100pg RNA and 21 then the two were injected together, 100pg each, for a total of 200pg RNA. reference gene. SOD1 was coinjected with 6 other genes to look for synthetic effects. 11 SOD1 was injected individually at 50pg RNA, the other gene was injected individually at 12 100pg RNA and then the two were injected together, 50pg each, for a total of 100pg 13 RNA. 14 15 Table 1 : Twenty-four candidates from first pass of screen (see Supplemantal Table 3 
64-93%
High expression in human heart [49] Expressed in the pharyngeal arches and limb buds at E10.5 [17] 
